Power Law company profile

CASI Pharmaceuticals

Biotech & Life Sciences · Rockville, United States · Founded 1991 · IPO 1996 Colt

CASI, we focus on building a pipeline through mutually beneficial business development transactions

Valuation

$19M

Market cap · Mar/2026

Revenue

$29M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

3 investors on CASI Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 3 investors entered at this stage

Panacea Venture

Venrock

Foresite Capital

Global footprint

Where CASI Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Rockville HQ

Book a demo for the full country breakdown

Web traffic by country

2.9K monthly visits
across markets

🇺🇸 United States93.1%

🇮🇳 India10.3%

Top 2 markets shown

Market sentiment

What the market is saying about CASI Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about CASI Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CASI Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles